Key result
Minimally invasive mitral valve surgery significantly reduced total postoperative stay (4.35 vs 6.95 days, P<0.001) and time to return to normal activity compared to conventional sternotomy.
Why the study?
Advancements in instruments, thoracoscopes, and cardiopulmonary bypass techniques have encouraged the adoption of minimally invasive mitral valve surgery, which has become standard for many surgeons and institutions.
Does minimally invasive mitral valve surgery via right lateral minithoracotomy improve postoperative recovery times compared to conventional median sternotomy in patients with mitral valve pathology?
Cohort (n=150)
No
Does minimally invasive mitral valve surgery via right lateral minithoracotomy improve postoperative recovery times compared to conventional median sternotomy in patients with mitral valve pathology?
Absolute Event Rate: 4.35% vs 6.95%
p-value: p=<0.001
Minimally invasive mitral valve surgery via right minithoracotomy significantly accelerates postoperative recovery and return to normal activity compared to conventional median sternotomy.
May support faster recovery with minithoracotomy; hypothesis-generating pending randomized confirmation.
BackgroundAdvancements in instruments and thoracoscopes and the evolution of cannulation techniques and cannulae types for cardiopulmonary bypass as well as cardiopulmonary bypass machines during the past decade have encouraged many surgeons to adopt minimally invasive mitral valve surgery (MIMVS). Today, MIMVS has become the standard approach for many surgeons and institutions.Patients and methodsThis is a nonrandomized prospective study in which 150 patients of mitral valve pathology scheduled for mitral valve surgery over a period of 3 years from March 2014 to May 2017 at National Heart Institute were allocated to two groups after fulfilling the inclusion criteria. Group 1 underwent conventional mitral valve surgery via median sternotomy and group 2 underwent MIMVS via right lateral minithoracotomy. Data were collected prospectively, and seven parameters were used to compare between study groups, namely, cross-clamp time, total bypass time, dose of inotrope, postoperative ventilation time, ICU stay time, total postoperative length of stay, and return to normal activity.ResultsDemographic criteria of the two cohorts were comparable. Mean bypass time in group 1 was 50.30 ± 7.56 min compared with 67.80 ± 5.85 min in group 2 (P < 0.001). Postoperative ventilation time in group 1 was 8.78 ± 2.1 h and postoperative ICU stay was 49.9 ± 11.55 h, whereas in group 2, postoperative ventilation time was 4.78 ± 1.66 h and postoperative ICU stay was 26.1 ± 7.98 h (P < 0.001 for both). Total postoperative stay was 6.95 ± 1.26 days in group 1 compared with 4.35 ± 1.55 days in group 2 (P < 0.001). Again, return to normal activity was 13.1 ± 4.41 weeks for group 1 compared with 4.45 ± 0.96 weeks in group 2 (P < 0.001).ConclusionIn appropriate patients with mitral valve disease of any cause, a right minithoracotomy approach can be used safely without compromising clinical outcome and with fast return to normal activity.
No takes yet. Share an insight, caveat, or question.
Abdelgawad et al. (2021) conducted a cohort in Mitral valve pathology (n=150). Minimally invasive mitral valve surgery via right lateral minithoracotomy vs. Conventional mitral valve surgery via median sternotomy was evaluated on Total postoperative length of stay (days) (p=<0.001). Minimally invasive mitral valve surgery significantly reduced total postoperative stay (4.35 vs 6.95 days, P<0.001) and time to return to normal activity compared to conventional sternotomy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: